Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
DESCRIPTION: Genetic and molecular studies have shown that the
Drosophila ovarian tumor gene functions at several key points during
oogenesis. Mutations in this gene can be roughly grouped into three
classes on the basis of the severity of the phenotype. The most severe
mutants fall into the quiescent class (QUI). The ovaries of these
mutants appear to lack germ cells altogether, and consist of small empty
sheaths of somatic tissue.The second phenotypic class, for which locus
was originally named, are the tumorous ovary alleles (ONC). In these
mutants germ line cells are present; however, oogenesis is arrested at
an early step and the ovary becomes populated with many, often hundreds,
of small undifferentiated germ cells. The third phenotypic class, DIF,
is least severe. The early steps in egg chamber formation often proceed
almost normally in this class of mutants; however some chambers are
formed which lack the oocyte or have abnormal numbers of nurse cells.
Other chambers appear almost wild type, but at late stages of oogenesis
the nurse cells in these chambers fail to dump their contents into the
oocyte. The range of phenotypic defects in the different classes is most
easily explained by a model which postulates that increasing levels otu
function are required as oogenesis proceeds. Other hints as to the
possible function of the otu product come from the observation that
several of the ONC alleles show defects in the expression of Sex-lethal
protein and the processing of Sxl mRNAs. Consistent with the idea that
otu is required for the proper expression of Sxl in the female germ line
is the finding that ONC mutants can be partially rescued by a
constitutive Sxl allele. However, facilitating Sxl expression is not
only function of otu since the consitutive Sxl allele has no effect on
the phenotypes of the QUI or DIF otu mutants.
No Sub Projects information available for 5R01GM052830-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM052830-03
Patents
No Patents information available for 5R01GM052830-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM052830-03
Clinical Studies
No Clinical Studies information available for 5R01GM052830-03
News and More
Related News Releases
No news release information available for 5R01GM052830-03
History
No Historical information available for 5R01GM052830-03
Similar Projects
No Similar Projects information available for 5R01GM052830-03